Time since prior fracture is a risk modifier for 10-year osteoporotic fractures

Journal of Bone and Mineral Research

Volumn 25, Issue 6, 2010, Pages 1400-1405

  Giangregorio, Lora M ^a,b,c   Leslie, William D ^d  

^a UNIVERSITY OF WATERLOO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c TORONTO REHABILITATION INSTITUTE   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Bone densitometry; Fracture; Osteoporosis; Population study; Risk assessment

Indexed keywords

ADULT; ANKLE FRACTURE; ARTICLE; BONE DENSITOMETRY; CLAVICLE FRACTURE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONFIDENCE INTERVAL; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FIBULA FRACTURE; FOLLOW UP; FOREARM FRACTURE; FRACTURE; HAZARD RATIO; HEALTH SERVICE; HIP FRACTURE; HUMAN; HUMERUS FRACTURE; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PATELLA FRACTURE; PELVIS FRACTURE; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RIB FRACTURE; RISK ASSESSMENT; RISK FACTOR; SCAPULA; SCORING SYSTEM; SPINE FRACTURE; STERNUM; TIBIA FRACTURE; TIME; TRUNK;

BONE DENSITY; CANADA; FEMALE; FRACTURES, BONE; HUMANS; INCIDENCE; MIDDLE AGED; ORGAN SPECIFICITY; OSTEOPOROSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TIME FACTORS;

EID: 77953532428     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.35     Document Type: Article

References (33)

1. Osteoporosis prevention, diagnosis and therapy, NIH consensus statements. 17th ed. 2000:1-45.
2. Adachi JD, Loannidis G, Berger C, et al. The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int. 2001;12:903-908.
3. Petrella RJ, Payne M, Myers A, Overend T, Chesworth B. Physical function and fear of falling after hip fracture rehabilitation in the elderly. Am J Phys Med Rehabil. 2000;79:154-160. (Pubitemid 30204798)
4. Wiktorowicz ME, Goeree R, Papaioannou A, Adachi JD, Papadimitropoulos E. Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporos Int. 2001;12:271-278.
5. MacLean C, Newberry S, Maglione M, et al. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med. 2008;148:197-213.
6. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994;843:1-129.
7. Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD. Low bone mineral density and fracture burden in postmenopausal women. CMAJ. 2007;177:575-580.
8. Siris ES, Chen YT, Abbott TA, et al. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med. 2004;164:1108-1112.
9. Kanis JA, Oden A, Johnell O, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007;18:1033-1046.
10. Kanis JA, Johnell O, De Laet C, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004;35:375-382. (Pubitemid 38953182)
11. Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD. Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum. 2006;35:293-305.
12. Dretakis KE, Dretakis EK, Papakitsou EF, Psarakis S, Steriopoulos K. Possible predisposing factors for the second hip fracture. Calcif Tissue Int. 1998;62:366-369.
13. Johnell O, Kanis JA, Oden A, et al. Fracture risk following an osteoporotic fracture. Osteoporos Int. 2004;15:175-179.
14. Nymark T, Lauritsen JM, Ovesen O, Rock ND, Jeune B. Short time-frame from first to second hip fracture in the Funen County Hip Fracture Study. Osteoporos Int. 2006;17:1353-1357.
15. von Friesendorff M, Besjakov J, Akesson K. Long-term survival and fracture risk after hip fracture: a 22-year follow-up in women. J Bone Miner Res. 2008;23:1832-1841.
16. Ryg J, Rejnmark L, Overgaard S, Brixen K, Vestergaard P. Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977-2001. J Bone Miner Res. 2009;24:1299-1307.
17. Leslie WD, Metge C. Establishing a regional bone density program: lessons from the Manitoba experience. J Clin Densitom. 2003;6:275-282.
18. Leslie WD, Caetano PA, Macwilliam LR, Finlayson GS. Construction and validation of a population-based bone densitometry database. J Clin Densitom. 2005;8:25-30.
19. Roos LL, Mustard CA, Nicol JP, et al. Registries and administrative data: organization and accuracy. Med Care. 1993;31:201-212.
20. Roos LL, Walld RK, Romano PS, Roberecki S. Short-term mortality after repair of hip fracture. Do Manitoba elderly do worse? Med Care. 1996;34:310-326.
21. Leslie WD. The importance of spectrum bias on bone density monitoring in clinical practice. Bone. 2006;39:361-368.
22. Binkley N, Kiebzak GM, Lewiecki EM, et al. Recalculation of the NHANES database SD improves T-score agreement and reduces osteoporosis prevalence. J Bone Miner Res. 2005;20:195-201.
23. Leslie WD, Tsang JF, Lix LM. Osteoporosis diagnosis and incident fracture as a function of prior fracture site in a large clinical cohort. J Bone Miner Res. 2008;23:S66.
24. Leslie WD, Tsang JF, Caetano PA, Lix LM. Effectiveness of bone density measurement for predicting osteoporotic fractures in clinical practice. J Clin Endocrinol Metab. 2007;92:77-81.
25. Adachi JD, Rizzoli R, Boonen S, Li Z, Meredith MP, Chesnut CH III. Vertebral fracture risk reduction with risedronate in post-menopausal women with osteoporosis: a meta-analysis of individual patient data. Aging Clin Exp Res. 2005;17:150-156.
26. Black DM, Thompson DE, Bauer DC, et al. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab. 2000;85:4118-4124.
27. Silverman SL, Watts NB, Delmas PD, Lange JL, Lindsay R. Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study. Osteoporos Int. 2007;18:25-34.
28. Cadarette SM, Katz JN, Brookhart MA, et al. Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004. J Rheumatol. 2008;35:319-326.
29. Chapurlat RD, Bauer DC, Nevitt M, Stone K, Cummings SR. Incidence and risk factors for a second hip fracture in elderly women. The Study of Osteoporotic Fractures. Osteoporos Int. 2003;14:130-136.
30. Berry SD, Samelson EJ, Hannan MT, et al. Second hip fracture in older men and women: the Framingham Study. Arch Intern Med. 2007;167:1971-1976.
31. Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA. 2009; 301:513-521.
32. Ioannidis G, Papaioannou A, Hopman WM, et al. Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. CMAJ. 2009;181:265-271.
33. Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B, Oglesby AK. The components of excess mortality after hip fracture. Bone. 2003; 32:468-473.